Company & Sponsor Intelligence
University of Bern
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed4
Countries1
Therapeutic footprint
alzheimersdepressionother_neurologysubstance_use
Indexed studies
NCT02792140The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams
other_neurology · SwitzerlandPHASE4
other_neurology · SwitzerlandPHASE4
NCT02968537Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders
substance_use · SwitzerlandNA
substance_use · SwitzerlandNA
NCT03351452tES Effects on Associative Memory Performance
alzheimers · SwitzerlandNA
alzheimers · SwitzerlandNA
NCT03742960Sleep Subtypes in Adolescent Depression
depression · SwitzerlandNA
depression · SwitzerlandNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →